In focus · trending topic

chemoembolization

2 stories · following the connections

Clinical Data Shows Surefire Technology Achieved 79% Objective Response versus 37% Using a Standard Microcatheter in Treating Primary Liver Cancer

By Nasdaq OMXMar 8, 2017, 11:00 AM UTC

Surefire Medical Launches New Flexion Guiding Catheter with Nitinol Tip for Better Shape Retention, Improved Back-up Support

By Nasdaq OMXMar 6, 2017, 11:00 AM UTC